Ziying Liu
Oncology · 2017
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 15 citations into it
- Electrical and Electronic Engineering — 5 citations into it
Whom Ziying Liu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Ziying Liu's perspective
Ordered by how strongly the researchers Ziying Liu trusts endorse each paper. Same corpus, a different order for every researcher.
- The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* (Journal of Biological Chemistry)
- Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration (Science)
- Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. (New England Journal of Medicine)
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
- Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor (Science)
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase (Nature)
- The PARP superfamily (Bioessays)
- Reciprocal Binding of PARP-1 and Histone H1 at Promoters Specifies Transcriptional Outcomes
- Toward a unified nomenclature for mammalian ADP-ribosyltransferases. (TIBS -Trends in Biochemical Sciences. Regular ed)
- Manipulation of a Nuclear NAD+ Salvage Pathway Delays Aging without Altering Steady-state NAD+ Levels* (Journal of Biological Chemistry)